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DNA damage contributes to cancer development and aging. Congenital syndromes that
affect DNA repair processes are characterized by cancer susceptibility, developmental
defects, and accelerated aging (Schumacher et al., 2008). DNAdamage interfereswithDNA
metabolism by blocking replication and transcription. DNA polymerase blockage leads to
replication arrest and can gives rise to genome instability. Transcription, on the other hand,
is an essential process for utilizing the information encoded in the genome. DNA damage
that interferes with transcription can lead to apoptosis and cellular senescence. Both
processes are powerful tumor suppressors (Bartek and Lukas, 2007). Cellular response
mechanisms to stalled RNA polymerase II complexes have only recently started to be
uncovered. Transcription-coupled DNA damage responses might thus play important roles
for the adjustments to DNA damage accumulation in the aging organism (Garinis et al.,
2009). Here we review human disorders that are caused by defects in genome stability
to explore the role of DNA damage in aging and disease. We discuss how the nucleotide
excision repair system functions at the interface of transcription and repair and conclude
with concepts how therapeutic targeting of transcription might be utilized in the treatment
of cancer.
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GENOME MAINTENANCE DEFECTS CAUSE CANCER
SUSCEPTIBILITY AND PREMATURE AGING
It was estimated that DNA damage occurs on the order of tens
of thousands per genome on a daily basis (Lindahl and Nyberg,
1972). Genotoxic insults can stem from a large variety of endoge-
nous and exogenous sources (Figure 1). Cellular metabolism can
produce reactive oxygen species (ROS) and alkylating agents, while
cells can be exposed to ultraviolet (UV), ionizing radiation (IR),
and a variety of genotoxic chemicals (Loeb and Harris, 2008).
The type of lesion can vary widely and depends on the source of
DNA damage. For example, ROS induces oxidative base modi-
ﬁcations, IR typically leads to single- and double-strand breaks
(SSB and DSB, respectively), DNA alkylation can lead to adduct
and interstrand crosslink (ICL) formation, and UV triggers the
formation of thymidine dimers (Hurley, 2002). The toxicity of
DNA damage depends on the structural changes they inﬂict as
well as the characteristics of the cell they occur in. Proliferating
cells have a different repertoire of DNA repair pathways than qui-
escent cells and, therefore, the same lesion might have different
effects in different tissues. In cycling cells, for instance, a single
DSB is sufﬁcient to impair chromosome segregation during mito-
sis and ICLs lead to replication fork collapse. For these reasons
even a small number of DSBs and ICLs can be cytotoxic. In con-
trast, oxidative base modiﬁcations are generally less obstructive,
while UV-induced cyclobutane pyrimidine dimers (CPDs) can be
read through by specialized DNA polymerases and thus, can per-
sist through replication, but pose an obstacle to transcription and
lead to stalling of RNA polymerases (RNAP).
Given the frequency and impact of DNAdamage, highly sophis-
ticated DNA repair systems have evolved. These systems recognize
speciﬁc types of lesions and induce DNA damage signaling. Fail-
ure of DNA repair has been associated with severe disorders
in humans, often associated with occurrence of cancer and/or
premature aging (Table 1).
DSB REPAIR AND THE DNA DAMAGE RESPONSE
The DNA damage response (DDR) to DSBs is particularly well-
understood. As the presence of a DSB poses a major obstacle
for further cell division a sophisticated network of DDR signal-
ing is ignited (Ciccia and Elledge, 2010). Genetic experiments
that were performed in yeast nearly 25 years ago established that
DNA damage checkpoints transiently halt cell cycle progression in
the presence of genotoxic stress to assure that the repair is com-
pleted before cell division (Weinert and Hartwell, 1989; Rowley
et al., 1992). The recognition that DDR defects are causal for can-
cer development has sparked major research efforts employing
model systems from yeast to mammals. The DNA damage check-
point mechanisms turned out to be highly conserved throughout
evolution. Multicellular organisms, however, not only respond
by transient cell cycle arrest but also by inducing cellular senes-
cence, thus permanently withdrawing from cell division, and
apoptosis, through which damaged cells commit suicide to no
longer pose a threat to the organism (Harper and Elledge, 2007).
Intriguingly, the DDR not only impacts on regulators of cellular
proliferation and cell death but impinges on a variety of cellular
processes such as transcription, DNA repair, respiration, energy
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FIGURE 1 | Diverse lesion types trigger DNA damage responses. DNA
damage can be caused by various genotoxic agents, such as reactive oxygen
species (ROS) produced during cellular metabolism, alkylating agents that
ﬁnd application in cancer therapy, ionizing irradiation (IR), which is used for
radio therapy, or ultraviolet (UV) irradiation presenting a daily threat as it is
contained in sunlight. The inﬂicted lesions are just as diverse, since ROS
usually lead to base modiﬁcations; alkylating agents form adducts, while
bifunctional alkylating agents crosslink DNA to form interstrand crosslinks
(ICLs). IR typically induces double-strand breaks (DSBs), and UV light
triggers the formation of cyclobutane pyrimidine dimers (CPDs) and
6,4-photoproducts (6,4-PPs). Cells have a repertoire to sense the different
lesions and subsequently activate DNA damage checkpoint proteins.
Ultimately, cells respond to the DNA damage by chromatin remodeling,
modiﬁed transcription, ﬁne-tuning of energy metabolism, cell cycle arrest,
activation of DNA repair pathways and in case of irreparable damage load,
induction of senescence or apoptosis.
metabolism, chromatin remodeling, and others (Figure 1; Jackson
and Bartek, 2009).
The initial recognition of DSBs involves binding of the trimeric
Mre11–Rad50–Nbs1 (MRN) complex consisting of MRE11,
NBS1, and RAD50 to the broken DNA ends (Bartek and Lukas,
2007). The MRN complex activates the PI3 kinase-like kinase
ataxia telangiectasia mutated (ATM), which in turn phosphory-
lates a plethora of targets (Shiloh, 2003). ATM targets include
the checkpoint kinase CHK2, which in turn activates p53. p53
then induces cell cycle arrest and amid severe damage apoptosis.
Mutations in p53 underlie Li–Fraumeni syndrome that causes a
strong cancer predisposition (Vogelstein et al., 2000). About half
of human cancers carry acquired mutations in p53, making it
a key tumor suppressor. As the importance of p53 in cancer
development has been recognized, research activity has been con-
tinuously expanding on this tumor suppressor molecule. Indeed,
p53 has been implicated in the regulation of a number of cel-
lular DDR outputs and more recently also in regulating non-
cell autonomous responses to DNA damage (Reinhardt and
Schumacher, 2012).
Cells with defective DSB repair, like ATM mutants, are
highly IR sensitive. Heritable mutations in ATM result in ataxia
telangiectasia (AT), a rare recessive syndrome that is associated
with progressive neurodegeneration, variable kinds of immune-
deﬁciencies and a predisposition to lymphoid cancer (Lavin,
2008). Patients with mutated NBS1 develop Nijmegen breakage
syndrome (NBS) and exhibit similar symptoms as seen in AT.
Most frequently the binding site of NBS1 to MRE11 and therefore
the MRN complex formation is disrupted (Maser et al., 2001). In
mice, complete loss of NBS1 is embryonic lethal, which is consis-
tent with embryonic lethality of MRE11 and RAD50 null mutants
(Xiao andWeaver, 1997; Friedberg andMeira, 2006). Nevertheless,
mutations affecting, but not abolishing, the binding of MRE11
to the other two subunits of the MRN complex lead to ataxia
telangiectasia-like disorder (ATLD) showing phenotypes distinct
from NBS. This suggests that MRE11 and NBS1 might have func-
tions independent from the MRN complex (Taylor et al., 2004).
While DNA damage checkpoint signaling halt the cell cycle, at
least two distinct DSB repair machineries are activated depend-
ing on the phase of the cell cycle (Chapman et al., 2012). In S/G2
phase homologous recombination (HR) uses the sister chromatid
as template for accurate repair, while during G1 non-homologous
end joining (NHEJ) ligates the broken ends after end resection.
Thereby NHEJ comprises a fast and efﬁcient but error prone DNA
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Table 1 | Human disorder associated with genome maintenance defects.




Ataxia telangiectasia AT ATM DSB repair + +
Ataxia telangiectasia-like
disorder
ATLD MRE11 DSB repair − (+)
Atypical Werner syndrome WS WRN nuclear structure + +





COFS CSB, xeroderma pigmentosum D
(XPD), XPG, ERCC1
TC-NER − +
Cockayne syndrome CS CSA, CSB TC-NER − +
Cockayne syndrome type II CS type II CSA, CSB TC-NER − +
Dyskeratosis congenita DKC DKC1, TERC1 Telomere maintenance + +
Fanconi anemia FA FANCA, B, C, D1 (BRCA2), D2, E,
F, G, I, J (BRIP1), L, M, N (PALB2),
O (RAD51C), and P (SLX4)
ICL repair + +
Hutchinson–Gilford-
progeria/syndrome
HGPS LMNA, ZMPSTE24 nuclear structure − +
Li–Fraumeni Syndrome p53 many (p53 tumor suppressor
inactivation)
+ −
Mandibuloacral dysplasia MAD LMNA, ZMPSTE24 nuclear structure − (+)
Nijmegen breakage syndrome NBS NBS1 DSB repair + (+)
Restrictive dermopathy RD ZMPSTE24 nuclear structure − +
Rothmund–Thomson
syndrome
RTS RECQL4 RECQ helicase + +
Trichothiodystrophy TTD TFIIH complex: XPD, xeroderma




UV-sensitive syndrome UVSS UVSSA NER − (+)
Werner syndrome WS WRN RECQ helicase, inﬂuencing
nuclear structure, DSB repair, ICL
repair, MMR, BER, TLS
+ +
Xeroderma pigmentosum XP XPA-G NER + −
repair method. However, for large parts of the genome the NHEJ-
induced errors can be tolerated when genes are not affected. Since
NHEJ is utilized when no sister chromatid is available, it is thought
to function mainly in non-proliferating cells like neurons (Jeppe-
sen et al., 2011). Nullmutations of NHEJ pathway proteins XRCC4
and LIG4 are embryonic lethal in mice. In 2001, LIG4 syndrome
has been described in humans that shares phenotypic similarities
with NBS but lacks cancer predisposition (O’Driscoll et al., 2001).
In the case of HR,both, reduced and elevated activity, have been
associated with a predisposition to cancer (Modesti and Kanaar,
2001). For example, dysfunctional BRCA1 and BRCA2 diminish
the efﬁciency of HR and germ line mutations in humans lead to
a high incidence of breast cancer (Moynahan et al., 1999, 2001).
Mouse models for Bloom’s syndrome (BLS), in contrast, display
hyperactive HR and exhibit a high tumor susceptibility (Luo et al.,
2000). It thus became apparent that the ﬁne-tuning of HR is
essential for maintaining genome stability.
ICL REPAIR
Like DSB repair, the employment of removal mechanisms of
ICLs alters depending on cell cycle stage. During G1 the excision
repair cross-complementation group 1–xeroderma pigmentosum
group F (ERCC1–XPF) endonuclease initiates the ICL removal
(Deans and West, 2011). When ICLs are encountered by the repli-
cation fork a Fanconi anemia (FA) protein complex comprised
of FANCA, -B, -C, -E, -F, -G, -L, and -M mono-ubiquitylates
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FANCD2 that interacts with DSB repair proteins including
the breast cancer susceptibility gene BRCA1, FANCD1/BRCA2,
FANCJ, and the MRN complex (Kee and D’Andrea, 2010).
BRCA1/FANCD2 and RAD51/FANCD2 complexes accumulate at
the site of damage and form foci during S-phase of cell cycle. Sub-
sequent repair is thought to be achieved byHRpathway (Taniguchi
et al., 2002).
The inability to repair ICLs in FA patients leads to replica-
tion fork collapses, particularly in actively dividing cells such as
the hematopoietic system. Consequently, FA is characterized by
bonemarrow failure due to chromosomal aberration and leukemic
transformation of cells. Also FA is characterized by cancer predis-
position andhypersensitivity to crosslinking agents likemitomycin
C, cisplatin, or diepoxybutane (Wang and Gautier, 2010).
RecQ HELICASES AND DNA REPAIR
Also the Werner protein (WRN) has been linked to DNA repair
when ICLs cause replication fork breakdown (Otterlei et al., 2006).
WRN has a recombination Q (RecQ) helicase and an exonucle-
ase domain and functions during replication and recombination
repair. Indeed, WRN has been shown to interact with proteins
of many different DNA repair pathways such as HR via RAD52
(Baynton et al., 2003), BRCA1 (Cheng et al., 2006), RAD51 (Otter-
lei et al., 2006), and NSB1 (Cheng et al., 2004), NHEJ via Ku70–80
(Cooper et al., 2000) and LIG4–XRCC4–XLF (Kusumoto et al.,
2008) complex, base excision repair (BER) via PARP1 (von Kobbe
et al., 2003) and mismatch repair (MMR) via interaction with
MSH2/MSH6, MSH2/MSH3, and MLH1/PMS2 complexes (Say-
dam et al., 2007). Taken together, this indicates that WRN might
be a multifunctional protein required during the repair of a variety
of DNA lesions.
Mutations in WRN underlie Werner syndrome (WS), which is
a rare autosomal recessive disease. WS patients not only exhibit
elevated cancer predisposition, but also develop symptoms of
premature aging. The progeroid features of WS patients are partic-
ularlywell recognized as a premature onset of aging as they develop
typically during the third decade of life. Classic forms of progeroid
syndromes are also found in patients carrying mutations in related
RecQ helicases. BLS, and Rothmund–Thomson syndrome (RTS)
are caused by mutations in the Bloom’s, and RECQL4 helicases,
respectively (Hickson, 2003; Bohr, 2008). Similar to WS, BLS and
RTS patients show a wide variety of progeroid features as well as
elevated cancer susceptibility.
TELOMERE MAINTENANCE
Genome instability can also be caused by shortening of telom-
eres. Telomeres are the end-capping structures that maintain the
integrity of linear chromosomes.With each cell cycle the telomeres
become shorter due to the end replication problem and require
telomerase for maintenance (de Lange, 2009). Most somatic cells
do not express telomerase and, consequently, progressive short-
ening limits the replicative lifespan of somatic cells. Critically
shortened telomeres are recognized as DSB and induce checkpoint
signaling leading to cellular senescence (Abdallah et al., 2009).
Cancer cells often re-express telomerase allowing them to contin-
uously grow. Also stem cells and germline compartments express
telomerase to maintain their replicative potential. Mutations in
the telomerase complex components, DKC1 and TERC1, lead to
dyskeratosis congenita (DKC), hallmarks of which include growth
and mental retardation, immune deﬁciency, and anemia (Mar-
rone et al., 2005; Armanios and Blackburn, 2012). Telomere length
appears to be correlated with life expectancy (Cawthon et al.,
2003), fueling the proposition that telomere length could serve
as predictive marker of biological aging.
NUCLEAR INSTABILITY AS A SOURCE FOR GENOTOXIC STRESS
Genome instability can also result from mechanical stress on the
nucleus. So called laminopathies such as Hutchinson–Gilford-
progeria-syndrome (HGPS), atypical WS, restrictive dermopathy
(RD), and mandibuloacral dysplasia (MAD) are caused by muta-
tions in lamin A and the ZMPSTE24 farnesyltransferase required
for lamin A processing (Ramirez et al., 2007). The nuclear insta-
bility leads to DNA damage accumulation and evokes a DDR.
HGPS ﬁbroblasts as well as mouse embryonic ﬁbroblasts (MEFs)
from Zmpste24−/− mice show elevated chromosomal instability
andDNAdamage sensitivity (Liu et al., 2005). It was suggested that
the nuclear envelope instability inHGPS interfereswith the correct
localization of the MRN complex and the recruitment of the DSB
repair factors 53BP1 and RAD51 (Liu et al., 2005; Constantinescu
et al., 2010). Consistent with enhanced genome instability, muta-
tions in p53 can partially alleviate the HGPS pathology in mice
(Varela et al., 2005). In addition to interfering with DNA repair,
nuclear envelope instability might also impair other essential
nuclear processes such as chromatin localization and modiﬁca-
tions and thus, gene expression (Burgess et al., 2012). Together
this combination might be accountable for the severe and highly
complex disease manifestation that characterizes laminopathies.
NUCLEOTIDE EXCISION REPAIR
Mutations innucleotide excision repair (NER)underlie a variety of
skin cancer predisposing and degenerative disorders (Cleaver et al.,
2009; Table 1). Unlike most of the progeroid syndromes discussed
above, mutations that affect the two distinct branches of NER are
linked either to cancer susceptibility or to premature aging. Defects
in the global genome (GG-) NER branch cause the skin can-
cer susceptibility syndrome xeroderma pigmentosum (XP), while
mutations affecting the transcription-coupled (TC-) NER branch
lead to progeroid syndromes such as Cockayne syndrome (CS)
that is characterized by postnatal growth retardation and acceler-
ated aging but not cancer (Lehmann, 2003). The distinct TC-NER
pathologies suggest that transcriptional impediments might be
particularly relevant to the aging process.
TRANSCRIPTION-COUPLED REPAIR IN AGING AND DISEASE
When the RNAPII is released from the transcription initiation
complex into the elongation phase it does not move uninterrupted
along the coding sequence (Larson et al., 2011). In vivo experi-
ments monitoring transcription elongation speed have revealed
that RNAPII often stalls even in the absence of exogenous DNA
damage. Transcription appears rather like stop-and-go trafﬁc than
a continuous process. This might have to do with spontaneous
DNA damage, structural tension, histone remodeling, or reg-
ulatory events, all of which might impede elongation. During
elongation, the transcription complex might also serve as control
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mechanism for DNA integrity, particularly in post-replicative cell
types. The sensitivity of ongoing transcription to stall at DNA
adductswas suggested to function as a“damagedosimeter”(Ljung-
man and Lane, 2004).WhenRNAPII stalls at a lesion, TC-NER ini-
tiates the NER reaction to remove a stretch of the damaged strand
(Hoeijmakers, 2001; Figure 2). The CSB protein, comprising a
switch/sucrose nonfermentable (SWI/SNF)-like DNA-dependent
ATPase, is associated with RNAPII and upon stalling recruits the
WD40 domain protein CSA. CSB is stabilized by the recently dis-
covered UV-stimulated scaffold protein A (UVSSA) protein that
ubiquitylates the stalled RNAPII (Nakazawa et al., 2012; Schwert-
man et al., 2012; Zhang et al., 2012). The CSB-dependent TC-NER
FIGURE 2 |Transcription at damaged DNA. (1) Prior to formation of the
transcription initiation complex, XPF–ERCC1 and XPG cut the DNA proximal to
the promoter to get ready for transcription initiation. TFIIH unwinds the DNA
to open the promoter during initiation phase. (2) CSB is bound to and moves
with RNAPII during elongation phase and can activate repair when the
polymerase gets stalled at a lesion. (3) Depending on the type of damage,
cells will undergo apoptosis upon stalling of RNAPII. Apoptosis can be
induced in a p53-dependent or -independent manner and might lead to tissue
degeneration and aging of the organism. (4) Opposing induction of cell death,
CSB can induce repair of the lesion byTC-NER. Removal of RNAPII is a
prerequisite for repair that is dependent on CSB and CSA. CSA is recruited by
CSB. UVSSA as well as NEDD4/Rsp5 and Cul3 are important for
polyubiquitylation of RNAPII via Cdc48/p97 and for stabilization of CSB at the
site of damage. RNAPII is degraded by the proteasome while CSB recruits
the factors of the downstream NER pathway. (5) XPA validates the lesion and
TFIIH unwinds the helix around the lesion. Replication protein A (RPA) coats
the single-stranded DNA to prevent the strand from reacting with other
factors or forming secondary structures. XPG is recruited 3’ of the damaged
DNA and stabilizes the XPF–ERCC1 endonuclease complex 5’ of the lesion. A
fragment of 25–30 nucleotides length containing the lesion is cut and
released. (6) Finally the gap is ﬁlled by DNA polymerase δ and ε, recruited by
replication factor C (RFC) and proliferative cell nuclear antigen A (PCNA), and
the nick is sealed by DNA ligase. (7) Re-initiation of transcription upon UV
irradiation requires CSB.
www.frontiersin.org February 2013 | Volume 4 | Article 19 | 5
“fgene-04-00019” — 2013/2/22 — 18:03 — page 6 — #6
Wolters and Schumacher Genome stability and aging
complex recruits the NER machinery including XPA and the 10-
subunit transcription factor II H (TFIIH) complex that comprises
XPB, XPD, and TTDA (p8). TFIIH locally unwinds the DNA and
recruits XPG to the 3′ side of the lesion, which in turn stabilizes
binding of theXPF–ERCC1heterodimer (also calledXFE) 5′ to the
lesion. Both XFE and XPG are endonucleases that incise the dam-
aged strand 25–30 nucleotides apart. The single-stranded stretch
is coated by RPA before the gap is ﬁlled by DNA polymerases δ and
ε that are recruited through RFC and PCNA. Finally, the nick is
sealed by DNA ligase. In response to transcription stalling also p53
can be activated to arrest the cell cycle or induce apoptosis (Ljung-
man, 2000). As part of resolving the transcriptional impasse,
degradation of the stalled RNAPII is induced by NEDD4/Rsp5
and Cul3-dependent ubiquitylation and subsequent proteasome
targeting through Cdc48/p97 (Anindya et al., 2007; Verma et al.,
2011). Outside of actively transcribed genes the XPC protein scans
for UV-induced lesions. Upon lesion detection the XPC–RAD23
and the DDB1–DDB2 complex recruit the same NER machinery
as the TC-NER complex (Cleaver et al., 2009).
Intriguingly, even though any mutation in NER genes confers
cellular UV sensitivity, the pathological consequences of muta-
tions affecting TC-NER or GG-NER are fundamentally different
(Hanawalt and Spivak, 2008). Most mutations in the TC-NER
factors CSA and CSB lead to CS that is characterized by devel-
opmental defects and premature aging with an onset at 3–4 years
of age. These classic types of CS exhibit neurological abnormali-
ties, limb ataxia, inner ear defects, cachexia, retinal degeneration,
postnatal growth retardation, progressive kyphosis, ataxia, and
photosensitivity but do not develop skin cancer (Laugel et al.,
2010). Mutations in CSA and CSB can also cause the more
severe CS type II as well as Cerebro-oculo-facio-skeletal syndrome
(COFS) that is diagnosed at birth with craniofacial and skele-
tal abnormalities, severely reduced muscle tone, and impairment
of reﬂexes. A third disorder caused by mutations in CSA, CSB,
and also UVSSA is UV-sensitive syndrome (UVSS). UVSS patients
show photosensitivity and mild freckling but no skin cancer pre-
disposition or neurological abnormalities. So far it has remained
elusive how nature and location of different mutations in CSA or
CSB are linked to the diverse phenotypic outcomes of the disease.
Certainly, stalled RNAPII complexes elicit a strong pro-apoptotic
signal. However, cell loss through apoptosis only explains a limited
part of the complex human diseases caused by TC-NER defects.
Consistent with a strong pro-apoptotic signal emanating from
stalled RNAPII, Csb mutations reduced cancer development in a
tumor prone mouse model (Lu et al., 2001). Mouse models for the
CS-related trichothiodystrophy (TTD)were protected from tumor
development (Wijnhoven et al., 2007). Taken together, these obser-
vations suggest that transcription impediments can have tumor
suppressive consequences.
In contrast toCS,a variety of mutations in theNERpathway can
give rise toXP that is characterized by pigmentation abnormalities,
photosensitivity, skin atrophy, and a 1000-fold elevated skin cancer
susceptibility (DiGiovanna and Kraemer, 2012). So far mutations
in seven XP genes, XPA-G, were found in XP patients. Intrigu-
ingly, mutations in XPC give rise to the speciﬁc skin phenotypes
in XP patients, while mutations in XP genes that function in the
NER pathway downstream of GG-NER and TC-NER, can result
in additional neurodegenerative phenotypes. The mutation spec-
trum of the XPD gene is particularly striking. Mutations in the
XPD subunit of TFIIH can give rise to XP, XP combined with CS
(XPCS),andTTD.TheTTDpathology that results frommutations
in XPB and XPD includes neurological and skeletal degeneration,
cachexia, ichthyosis (scaling of the skin), and characteristic brit-
tle hair and nails. Especially the brittle structure of the hair and
nails has been linked to defects in completing transcription leading
to deﬁciency of high-sulfur matrix proteins (Hoeijmakers, 2001;
Lehmann, 2003).
Notably, neurodegeneration is a very common trait not only
of NER deﬁciencies but it is associated with many of the disor-
ders that are caused by DNA repair defects. It is conceivable that
neurons are highly susceptible to DNA damage. Most neurons
are irreplaceable and thus, permanently lost when removed by
apoptosis. Moreover neurons exhibit a high oxygen metabolism
rate and low antioxidant levels (Barzilai et al., 2008), which might
elicit genotoxic stress in this cell type.
TISSUE MAINTENANCE AT THE COST OF RENEWAL AND
GROWTH
DNA damage checkpoint mediated proliferation arrest and apop-
tosis can explain some of the degenerative features of genome
instability syndromes. However, the wide variety of phenotypic
manifestations in the diverse progeroid syndromes suggests that
more complex organismal responses are involved. Indeed, recent
studies in mice have revealed endocrine adjustments that might
explain some of the disease outcomes. Mouse models for CS and
XFE progeria as well as HGPS mice and mutants in Sirt6 exhibit
severe growth defects and degenerative phenotypes mirroring the
human disorders (Mostoslavsky et al., 2006; Niedernhofer et al.,
2006; van der Pluijm et al., 2006; Mariño et al., 2010). The histone
deacetylase Sirt6 is required for genome stability, likely through its
role in DSB repair (Kaidi et al., 2010). Intriguingly, all those mouse
mutants show low circulating levels of the insulin-like growth fac-
tor (IGF)-1. IGF-1 is an essential component of the somatotropic
axis that regulates body growth through IGF-1 receptor (IGF-1R)
mediated mitogenic signaling (Carter et al., 2002). IGF-1 secre-
tion is triggered by growth hormone receptor (GHR) activation
in response to pituitary GH. Abrogated GHR signaling either
due to pituitary defects leading to failure of GH production or
knockout of Ghr itself leads to severely reduced body growth but
extension of lifespan (Bartke, 2009). In fact mutations in Igf-1r
confer lifespan extension in worms, ﬂies, and mammals indica-
tive of a highly conserved longevity assurance pathway (Kenyon,
2001). Mechanistically, it was demonstrated that in response to
transcription-blocking lesions cells downregulate GHR and IGF-
1R levels and activity (Garinis et al., 2009). This response conferred
reduced cell proliferation and enhanced stress resistance. Persis-
tence of transcription-blocking lesions even at low levels leads to
a prolonged GHR/IGF-1R attenuation. The reduction of soma-
totropic signaling might shift the endocrine environment from
growth to maintenance, thus accounting for growth failures and
perhaps also contributing to the tumor protection, for instance
in CS patients (Schumacher et al., 2008; Schumacher, 2009).
Enhanced cellular stress resistance on the other hand, is associated
with extended longevity in various species including mice. It
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was thus proposed that amid persistent DNA damage organisms
evoke a “survival” response through somatotropic attenuation
to preserve tissue maintenance and antagonize the detrimental
consequences of genome instability (Schumacher et al., 2008).
AT THE INTERFACE OF TRANSCRIPTION AND REPAIR
Mechanistically, the complexity and heterogeneity of the syn-
dromes that are caused by mutations in NER genes suggests that
the consequences of these mutations might go beyond the fail-
ure to remove DNA lesions. Intriguingly, the TFIIH factor has
been initially identiﬁed as basal transcription factor functioning
in the initiation phase of RNAPII-driven transcription (Egly and
Coin, 2011). The helicase activity of TFIIH not only unwinds the
double helix at sites of UV-induced lesions but also opens the
promoter (Figure 2). In addition, TFIIH has been implicated in
transcription that is mediated by RNAPI (Iben et al., 2002). Given
the role in transcription, CS and TTD have been suggested to
result primarily from transcription defects, rather than persistence
of transcription-blocking lesions (Kamileri et al., 2012a). Indeed,
not only TFIIH but evenly many other NER factors have recently
been demonstrated to play a role in basal transcription (Le May
et al., 2010). Furthermore, RNAPII stalling itself might have far-
reaching consequences. For example CSB is not only required for
initiating NER but also for re-initiating transcription upon UV
irradiation (Proietti-De-Santis et al., 2006; Figure 2). Stalling of
transcription complexes can also have detrimental consequences
for the cell when for example a replication fork collides with a
blocked RNAPII complex (Poveda et al., 2011).
Some of the degenerative phenotypes are likely to be caused by
apoptotic responses to RNAPII stalling. During the repair process
the NER complex is assembled in a highly dynamic manner as
revealed by real-time imaging of green ﬂuorescent protein (GFP)-
tagged NER proteins in cell culture (Luijsterburg et al., 2010). This
methodology is based on ﬂuorescence recovery after photobleach-
ing (FRAP) where subnuclear bleaching of the GFP tag allows
visualization of the protein exchange with the unbleached fraction
(Houtsmuller and Vermeulen, 2001). The dynamic FRAP experi-
ments have been systematically performed for many NER factors.
Intriguingly, it appears that the most time consuming step in the
NER reaction is the veriﬁcation of the damage (Luijsterburg et al.,
2010). This veriﬁcation step might be particularly important as
CPDs form rather subtle alterations in the double helix structure
and need to be distinguished from normal structural dynamics of
chromatin.
TheDNAbinding properties of NERproteins have been probed
by chromatin immunoprecipitation (ChIP) experiments (Le May
et al., 2010). Here, the endogenous proteins are isolated together
with the protein–DNA complex they are bound to. These studies
revealed that NER proteins are bound at speciﬁc gene promot-
ers and are needed for normal transcription independent of their
DNA repair function (Le May et al., 2010; Kamileri et al., 2012b).
Moreover, mutations in NER genes lead to a failure to initiate
transcription of nuclear receptor-induced genes (Le May et al.,
2010). Upon nuclear receptor activation the NER proteins XPC,
CSB, XPA, XPG, and XPF–ERCC1 are recruited to the promoter.
XPC, which previously was thought to function in GG-NER only,
was found to initiate transcription, while CSB remains associated
with RNAPII during elongation (Figure 2). XPC also mediates
initiation of the transcription of the stem cell inducer Nanog
together with Oct4/Sox2 (Fong et al., 2011). The XPF–ERCC1 and
XPG endonucleases incise DNA proximal to the promoter and are
required for the demethylation that precedes transcription initi-
ation (Le May et al., 2012). Interestingly, Ercc1 deﬁciency leads
to cell differentiation failures. Gene expression analysis of Ercc1
knockout mice showed strong resemblance with Taf10 mutants
(Kamileri et al., 2012b). TAF10 comprises a subunit of the TFIID
complex that mediates transcription initiation. Ercc1 like Taf10
mutants fail to transcribe genes that are normally induced post-
natally to facilitate developmental growth. Together, these data
suggest that developmental abnormalities in NER mutants result
from a failure to initiate developmental gene transcription pro-
grams. It remains to be established how transcription-blockage,
re-initiation, and de novo initiation are interconnected. It seems
conceivable that DNA damage surveillance in open reading frames
might be tightly linked with transcription initiation and pro-
moter clearance of RNAPII. In patients carrying mutations in
NER, the requirement of NER factors for transcription might even
exacerbate the consequences of the repair defect.
Not only factors acting in NER but also the proteins that are
dysfunctional in HGPS and WS have been connected to transcrip-
tion. Disruptionof nuclear structure by transfectionof a dominant
negative lamin A mutant is followed by reduced transcription as
measured by bromouridine-triphosphate (BrUTP) incorporation
(Spann et al., 2002). Furthermore, the incorporation of nucleoside
analogs and, therefore, efﬁcient transcription has been reported to
be impaired in cells with mutations in Werner’s helicase (Bala-
jee et al., 1999). Consequently, it is likely that the highly complex
progeroid syndromes result from imbalances in DNA metabolism,
and in particular, transcription impediments that can be fueled by
unrepaired DNA lesions.
OUTLOOK: TARGETING TRANSCRIPTION IN THERAPY
Taken together several lines of evidence indicate that responses
to transcription-blocking lesions are powerful tumor suppressors.
Particularly, the apparent cancer protection in TC-NER defec-
tive patients suggests that cellular growth impairment together
with pro-apoptotic signaling in response to RNAPII stalling
could effectively limit cancer cell proliferation. Importantly, there
are p53-dependent as well as -independent responses making
transcription-blockage mediated tumor suppression also relevant
when p53 is mutated (Ljungman and Lane, 2004; Garinis et al.,
2009). Indeed, it was proposed that targeting of transcription
might be a useful therapeutic strategy for cancer treatment (Ljung-
man and Lane, 2004). Several chemotherapies affect transcription
and part of the effector mechanisms might actually depend on
RNAPII stalling. More speciﬁcally, the illudin S derivative iro-
fulven has been developed to target sarcomas (Paci et al., 2006).
Illudin S and irofulven are highly cyotoxic to cells that are TC-
NER deﬁcient, indicating that the induced lesions lead to RNAPII
blockage (Jaspers et al., 2002). Trabectedin (ET-743, Yondelis), in
contrast, becomes toxic when the TC-NER reaction is activated
and produces a cytotoxic repair intermediate (Takebayashi et al.,
2001). The NER component ERCC1, through its functioning in
ICL removal, has been implicated in the resistance to cisplatin,
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which is commonly used to treat lung carcinoma (McNeil and
Melton, 2012). Moreover, cisplatin-induced DNA damage has
been shown to be removed faster when NER proteins are over-
expressed, whereas mutations in NER confer hypersensitivity to
the treatment (Kelland, 2007). Given the involvement of NER, it
has been suggested to apply ﬂudarabine nucleoside in combina-
tion with cisplatin to treat cancer. Fludarabine could inhibit NER
reaction at the repair synthesis step and by doing so, hypersensitize
cells to lesions normally repaired by NER (Li et al., 1997). It will be
important to establishwhether status of NER factors canbepredic-
tive of therapy outcome and, likewise, whether targeting of NER
might open new avenues to support speciﬁc types of chemother-
apy. Also topoisomerase inhibitors that are frequently used in
chemotherapy have been suggested to interfere with transcrip-
tion. Camptothecin, inhibiting topoisomerase I, and doxorubicin,
targetingDNA topoisomerase II, interfere with elongation and ini-
tiation of transcription, respectively, and are, therefore, efﬁcient
inducers of apoptosis in cancer cells (Ljungman and Lane, 2004).
The responses to transcription-blockage, namely attenuation
of the somatotropic axis, might also provide targets for thera-
pies aimed to prevent age-related diseases (Schumacher, 2009).
An early shift to the maintenance program, for instance through
inhibition of IGF-1R signaling, might delay the onset of age-
related disease. Igf-1r mice are not only protected from aging but
also from neurodegenerative diseases as demonstrated in mouse
models for Alzheimer’s disease (Cohen et al., 2009; Freude et al.,
2009). There are nearly a dozen compounds that target IGF-1
mediated signal transduction. These were originally developed
for use in cancer treatment to antagonize IGF-1 mediated mito-
genic signaling (Carter et al., 2002). Although many cancer cells
are critically dependent on IGF-1 signaling, it is likely that due
to their inherent genome instability cancer cells can mutate and
bypass this requirement for continuous proliferation. Nonetheless,
IGF-1 inhibitors might become useful in preventive treatment for
age-related diseases. Consistent with this concept, inhibition of
mTOR, a downstream component of IGF-1 signal transduction,
by rapamycin extends lifespan of various mouse strains (Harrison
et al., 2009).
In conclusion, it will be of pivotal importance to establish the
role of transcription impairments in progeroid syndromes and
during the course of DNA damage accumulation with aging. It
will be particularly interesting to further explore the distinct con-
sequences of impaired transcription elongation and initiation and
to establish how cellular responsemechanisms to stalled transcrip-
tion complexes impact on the physiological adjustments of the
aging organism.
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